We create innovative systems to extract high value
information from the world's genomic data for biotechnology and
personalized medicine. Our technology has already proved valuable in
biomedical research and plant breeding with unique capabilities for
gene and biomarker discovery, target analysis and drug repurposing.
- Nebion's Board of Directors and the Management Team have a
strong scientific record in computer science and biology.
- The software development and biocuration teams work
tightly together to build our search engine. This
multi-disciplinary integration between all company teams allows us to provide expert
services and experienced support to our customers.
- Nebion strongly promotes innovation and carefully protects
its intellectual property.
Research and Innovation
CTI Innovation Projects The Swiss Commission for Technology
and Innovation (CTI) co-funded a project in partnership with ETH. The
project led to the development of novel methods for large-scale
biological data integration, data curation, and to the development of
ontologies. A further CTI project in partnership with several
academic institutions and start-up companies is running in the field
of biomarker discovery in cancer and cardiovascular diseases.
SystemsX Bridge-to-Industry Project Nebion and ETH Zurich
have partnered to develop novel methodologies for the integration and
visualization of biclustering results. The project is co-funded by
SystemsX.ch and Nebion. See also project page at Systems X.
European FP7 Projects Nebion is a member of two large
European research projects, one in cardiovascular disease research
and the other in plant biology.
- TransCard is an EU FP7 collaborative
project to identify, prioritize and validate existing and emerging
targets and novel key regulators of lipid and lipoprotein metabolism.
The acronym stands for "Translating disease to cardiovascular
health". As partner of this project, Nebion will use its technologies
to identify novel targets and prioritize the consortium's markers,
identify novel genes associated with these diseases, curate and
integrate CVD-related datasets and develop specific tools. See also project
- 3to4 is
a large EU FP7 collaborative project to uncover mechanisms underlying
important aspects of the C4 leaf and study ways to transfer C4 traits
to C3 plants. As an SME, Nebion will provide expertise and services
to manage the consortium's high-throughput biological data, develop
novel tools and support data analysis. See also project website
Nebion Partnership Projects Nebion conducts several additional
innovative projects with various partners in the field of target identification, biomarker
search, gene expression and next generation sequencing.